作者
Josef S Smolen, Ferdinand C Breedveld, Gerd R Burmester, Vivian Bykerk, Maxime Dougados, Paul Emery, Tore K Kvien, M Victoria Navarro-Compán, Susan Oliver, Monika Schoels, Marieke Scholte-Voshaar, Tanja Stamm, Michaela Stoffer, Tsutomu Takeuchi, Daniel Aletaha, Jose Louis Andreu, Martin Aringer, Martin Bergman, Neil Betteridge, Hans Bijlsma, Harald Burkhardt, Mario Cardiel, Bernard Combe, Patrick Durez, Joao Eurico Fonseca, Alan Gibofsky, Juan J Gomez-Reino, Winfried Graninger, Pekka Hannonen, Boulos Haraoui, Marios Kouloumas, Robert Landewe, Emilio Martin-Mola, Peter Nash, Mikkel Ostergaard, Andrew Östör, Pam Richards, Tuulikki Sokka-Isler, Carter Thorne, Athanasios G Tzioufas, Ronald Van Vollenhoven, Martinus De Wit, Desirée Van Der Heijde
发表日期
2016/1/1
来源
Annals of the rheumatic diseases
卷号
75
期号
1
页码范围
3-15
出版商
BMJ Publishing Group Ltd
简介
Background
Reaching the therapeutic target of remission or low-disease activity has improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target recommendations, formulated in 2010, have provided a basis for implementation of a strategic approach towards this therapeutic goal in routine clinical practice, but these recommendations need to be re-evaluated for appropriateness and practicability in the light of new insights.
Objective
To update the 2010 treat-to-target recommendations based on systematic literature reviews (SLR) and expert opinion.
Methods
A task force of rheumatologists, patients and a nurse specialist assessed the SLR results and evaluated the individual items of the 2010 recommendations accordingly, reformulating many of the items. These were subsequently discussed, amended and voted upon by >40 experts, including 5 patients, from various regions of the …
学术搜索中的文章
JS Smolen, FC Breedveld, GR Burmester, V Bykerk… - Annals of the rheumatic diseases, 2016